About Index Trending news
Analyze
Pricing
Amgen Inc.

Amgen Inc.

Work at Amgen Inc.? Add yourself to this profile

Amgen Inc.

Amgen engages in the development of human therapeutic products in supportive ofcancer care, inflammation, nephrology and bone diseases.

Elsewhere

Contributors to this profile

Alexa global traffic share

Twitter followers

25 Apr 2017
$29,000,000
Venture capital (Series C)

GV joins $29 million investment into Science 37 to bring clinical trials to the home

VentureBeat
+1
20 Jul 2016
$11,900,000
Venture capital (Series B)
Amgen Ventures, Merck Ventures

Amgen and Merck KGaA Invest in Bostons Akili Increasing Funding Round to 42 4 Million

biospace
+1
08 Mar 2016
$43,000,000
Venture capital (Series B)
Added by

Tizona Therapeutics Closes $43M Series B Funding

FinSMEs
07 Jan 2016
$29,500,000
Venture capital (Series D)
Polaris Partners, OrbiMed, Topspin Partners, +6
Added by

Alector Raises $29.5M in Series D Financing

FinSMEs
18 Feb 2015
$8,500,000
Venture capital (Series C)
Atlas Venture, Boulder Ventures, Broadview Ventures, +2
10 Jan 2014
$13,500,000
Venture capital (Series B)
Added by

Atara Biotherapeutics Holds $13.5M Second Close of Series B Financing

FinSMEs
17 Dec 2013
$38,500,000
Venture capital (Series B)
Added by

Atara Biotherapeutics Secures $38.5M in Series B Financing

FinSMEs
14 Jul 2005
Venture capital (Series A)
Added by

PE Week Wire - Friday, July 15

PE Hub